|
17
|
99
|
1u8gA |
Crystal structure of a hiv-1 protease in complex with peptidomimetic inhibitor ki2-phe-glu-glu-nh2 |
|
17
|
99
|
1tsuA |
Crystal structure of decamer ncp1 substrate peptide in complex with wild-type d25n hiv-1 protease variant |
|
17
|
99
|
1tw7A |
Wide open 1.3a structure of a multi-drug resistant hiv-1 protease represents a novel drug target |
|
16
|
99
|
1tcxA |
Hiv triple mutant protease complexed with inhibitor sb203386 |
|
19
|
99
|
1tsqA |
Crystal structure of ap2v substrate variant of nc-p1 decamer peptide in complex with v82a/d25n hiv-1 protease mutant |
|
15
|
99
|
1tcwA |
Siv protease complexed with inhibitor sb203386 |
|
18
|
99
|
1sp5A |
Crystal structure of hiv-1 protease complexed with a product of autoproteolysis |
|
17
|
99
|
1t7iA |
The structural and thermodynamic basis for the binding of tmc114, a next-generation hiv-1 protease inhibitor. |
|
15
|
99
|
1t7kA |
Crystal structure of hiv protease complexed with arylsulfonamide azacyclic urea |
|
15
|
99
|
1sivA |
Three-dimensional structure of a siv protease(slash)inhibitor complex. implications for the design of hiv-1 and hiv-2 protease inhibitors |
|
19
|
99
|
1t7jA |
Crystal structure of inhibitor amprenavir in complex with a multi-drug resistant variant of hiv-1 protease (l63p/v82t/i84v) |
|
18
|
99
|
1t3rA |
Hiv protease wild-type in complex with tmc114 inhibitor |
|
15
|
99
|
1sh9A |
Comparing the accumulation of active site and non-active site mutations in the hiv-1 protease |
|
17
|
99
|
1sbgA |
An orally-bioavailable hiv-1 protease inhibitor containing an imidazole-derived peptide bond replacement. crystallographic and pharmacokinetic analysis |
|
17
|
99
|
1sdtA |
Crystal structures of hiv protease v82a and l90m mutants reveal changes in indinavir binding site. |
|
16
|
99
|
1sguA |
Comparing the accumulation of active site and non-active site mutations in the hiv-1 protease |
|
12
|
99
|
1sipA |
Alternative native flap conformation revealed by 2.3 angstroms resolution structure of siv proteinase |
|
16
|
99
|
1sdvA |
Crystal structures of hiv protease v82a and l90m mutants reveal changes in indinavir binding site. |
|
15
|
99
|
1rv7A |
Crystal structures of a multidrug-resistant hiv-1 protease reveal an expanded active site cavity |
|
18
|
99
|
1sduA |
Crystal structures of hiv protease v82a and l90m mutants reveal changes in indinavir binding site. |
|
14
|
99
|
1rq9A |
Crystal structures of a multidrug-resistant hiv-1 protease reveal an expanded active site cavity |
|
17
|
99
|
1rpiA |
Crystal structures of a multidrug-resistant hiv-1 protease reveal an expanded active site cavity |
|
20
|
99
|
1rl8A |
Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir |
|
15
|
99
|
1qbsA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
18
|
99
|
1qbuA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
16
|
99
|
1qbtA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
17
|
99
|
1qbrA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
17
|
99
|
1proA |
Hiv-1 protease dimer complexed with a-98881 |
|
15
|
99
|
1ohrA |
Viracept (r) (nelfinavir mesylate, ag1343): a potent orally bioavailable inhibitor of hiv-1 protease |
|
17
|
99
|
1odwA |
Native hiv-1 proteinase |
|
15
|
99
|
1odxA |
Hiv-1 proteinase mutant a71t, v82a |
|
17
|
99
|
1odyA |
Hiv-1 protease complexed with an inhibitor lp-130 |
|
15
|
99
|
1npaA |
Crystal structure of hiv-1 protease-hup |
|
15
|
99
|
1npwA |
Crystal structure of hiv protease complexed with lgz479 |
|
17
|
99
|
1nh0A |
1.03 a structure of hiv-1 protease: inhibitor binding inside and outside the active site |
|
9
|
107
|
1nsoA |
Folded monomer of protease from mason-pfizer monkey virus |
|
15
|
99
|
1npvA |
Crystal structure of hiv-1 protease complexed with ldc271 |
|
18
|
99
|
1mt7A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
13
|
99
|
1mrxA |
Structure of hiv protease (mutant q7k l33i l63i v82f i84v ) complexed with kni-577 |
|
17
|
99
|
1mtbA |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
16
|
99
|
1mtrA |
Hiv-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitor |
|
17
|
99
|
1mt8A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
13
|
99
|
1n49A |
Viability of a drug-resistant hiv-1 protease variant: structural insights for better anti-viral therapy |
|
15
|
99
|
1msmA |
The hiv protease (mutant q7k l33i l63i) complexed with kni-764 (an inhibitor) |
|
18
|
99
|
1mt9A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
15
|
99
|
1muiA |
Crystal structure of hiv-1 protease complexed with lopinavir. |
|
14
|
99
|
1mrwA |
Structure of hiv protease (mutant q7k l33i l63i) complexed with kni-577 |
|
15
|
99
|
1msnA |
The hiv protease (mutant q7k l33i l63i v82f i84v) complexed with kni-764 (an inhibitor) |
|
22
|
124
|
1mvpA |
Structural studies of the retroviral proteinase from avian myeloblastosis associated virus |
|
16
|
99
|
1meuA |
Hiv-1 mutant (v82f, i84v) protease complexed with dmp323 |
